<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR26">
 <label>26.</label>
 <mixed-citation publication-type="other">(1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 102(3 Pt 1):531â€“537</mixed-citation>
</ref>
